Expression and clinical significance of leptin, the functional receptor of leptin (OB-Rb) and HER-2 in non-small-cell lung cancer: A retrospective analysis

Journal of Cancer Research and Clinical Oncology

Volumn 137, Issue 12, 2011, Pages 1841-1848

  Xu, Yan Jie ^a   Shao, Yong Feng ^a   Zhao, Xia ^b   Geng, Yi Ting ^a   Wang, Kai ^a   Yin, Yong Mei ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b NANJING CHEST HOSPITAL   (China)

Author keywords

HER 2; Leptin; Non small cell lung cancer; OB Rb

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; LEPTIN; LEPTIN RECEPTOR;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; FEMALE; HAZARD RATIO; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; UNIVARIATE ANALYSIS;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LEPTIN; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROGNOSIS; RECEPTOR, ERBB-2; RECEPTORS, LEPTIN; RETROSPECTIVE STUDIES;

EID: 82955240678     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-011-1054-5     Document Type: Article

References (30)

1. A Bouloumié C Drexlerh M Lafontan R Busse 1998 Leptin, the product of Ob gene, promotes angiogenesis Circ Res 83 1059 1066 9815153 (Pubitemid 28520935)
2. S Catalano S Marsico C Giordano L Mauro P Rizza ML Panno S Andò 2003 Leptin enhances, via AP-1, expression of aromatase in the MCF-7 cell line J Biol Chem 278 28668 28676 12734209 10.1074/jbc.M301695200 1:CAS:528: DC%2BD3sXlsl2nur8%3D (Pubitemid 36935773)
3. D Cirillo AM Rachiglio R la Montagna A Giordano N Normanno 2008 Leptin signaling in breast cancer: an overview J Cell Biochem 105 956 964 18821585 10.1002/jcb.21911 1:CAS:528:DC%2BD1cXhtl2hsLbP
4. A Eisenberg E Biener M Charlier RV Krishnan J Djiane B Herman A Gertler 2004 Transactivation of erbB2 by short and long isoforms of leptin receptors FEBS Lett 565 139 142 15135067 10.1016/j.febslet.2004.03.089 1:CAS:528:DC%2BD2cXjvVGrs7w%3D (Pubitemid 38595334)
5. J Fijolek E Wiatr E Rowinska-Zakrewska D Giedronowicz R Langfort M Chabowski T Orłowski K Roszkowski 2006 P53 and Her2/neu expression in relation to chemotherapy response in patients with non-small cell lung cancer Int J Biol Markers 21 81 87 16847810 1:CAS:528:DC%2BD28XpvFWktLs%3D (Pubitemid 44210036)
6. E Fiorio A Mercanti M Terrasi R Micciolo A Remo A Auriemma A Molino V Parolin B Di Stefano F Bonetti A Giordano GL Cetto E Surmacz 2008 Leptin/HER2 crosstalk in breast cancer: in vitro study and preliminary in vivo analysis BMC Cancer 8 305 18945363 10.1186/1471-2407-8-305
7. G Frühbeck 2006 Intracellular signalling pathways activated by leptin Biochem J 393 7 20 16336196 10.1042/BJ20051578 (Pubitemid 43049298)
8. XL Fu XZ Zhu DR Shi LZ Xiu LJ Wang S Zhao H Qian HF Lu YB Xiang GL Jiang 1999 Study of prognostic predictors for non-small cell lung cancer Lung Cancer 23 143 152 10217618 10.1016/S0169-5002(99)00009-4 1:STN:280:DyaK1M3jtF2ksg%3D%3D (Pubitemid 29123884)
9. C Garofalo E Surmacz 2006 Leptin and cancer J Cell Physiol 207 12 22 16110483 10.1002/jcp.20472 1:CAS:528:DC%2BD28XisFOjsr4%3D
10. A Giatromanolaki MI Koukourakis K O'Byrne L Kaklamanis C Dicoglou E Trichia R Whitehouse AL Harris KC Gatter 1996 Non-small cell lung cancer: c-erbB-2 overexpression correlates with low angiogenesis and poor prognosis Anticancer Res 16 3819 3825 9042264 1:STN:280:DyaK2s7psVyhtA%3D%3D (Pubitemid 27085055)
11. H Han RJ Landreneau TS Santucci MY Tung RS Macherey SE Shackney CD Sturgis SS Raab JF Silverman 2002 Prognostic value of immunohistochemical expression of P53, HER2/neu and bcl-2 in stage 1 non-small cell lung cancer Hum Pathol 33 105 110 11823980 10.1053/hupa.2002.30183 1:CAS:528: DC%2BD38XhsVGku7s%3D (Pubitemid 34112959)
12. DF Hayes AD Thor 2002 C-erbB-2 in breast cancer: development of a clinically useful marker Semin Oncol 29 231 245 12063676 10.1053/sonc.2002.32899 1:CAS:528:DC%2BD38Xltlaqt70%3D (Pubitemid 34620440)
13. FR Hirsch WA Franklin R Veve M Varella-Garcia PA Bunn Jr 2002 Her2/neu expression in malignant lung tumors Semin Oncol 29 51 58 11894014 10.1053/sonc.2002.31523 1:CAS:528:DC%2BD38XjtVKjsr0%3D (Pubitemid 34226519)
14. SJ Hong KW Kwon SG Kim BM Ko CB Ryu YS Kim JH Moon JY Cho JS Lee MS Lee CS Shim BS Kim 2006 Variation in expression of gastric leptin according to differentiation and growth pattern in gastric adenocarcinoma Cytokine 33 66 71 16434209 10.1016/j.cyto.2005.11.015 1:CAS:528:DC%2BD28XisF2htLY%3D
15. M Ishikawa J Kitayama H Nagawa 2004 Enhanced expression of leptin and leptin receptor (OB-R) in human breast cancer Clin Cancer Res 10 4325 4331 15240518 10.1158/1078-0432.CCR-03-0749 1:CAS:528:DC%2BD2cXlsVWls7c%3D (Pubitemid 38878870)
16. R Janeckova 2001 The role of leptin in human physiology and pathophysiology Physiol Res 50 443 459 11702849 1:CAS:528:DC%2BD38XislegtQ%3D%3D (Pubitemid 33044217)
17. J Kern R Slebos B Top S Rodenhuis D Lager RA Robinson D Weiner DA Schwartz 1994 C-erbB-2 expression and codon12 K-ras mutations both predict shortened survival for patients with pulmonary adenocarcinomas J Clin Invest 93 516 520 7906694 10.1172/JCI117001 1:STN:280:DyaK2c7lslSltQ%3D%3D (Pubitemid 24072790)
18. G Kristiansen Y Yu S Petersen O Kaufmann K Schlüns M Dietel I Petersen 2001 Overexpression of c-erbB2 protein correlates with disease-stage and chromosomal gain at the c-erbB2 locus in non-small cell lung cancer Eur J Cancer 37 1089 1095 11378338 10.1016/S0959-8049(01)00096-X 1:CAS:528: DC%2BD3MXjvV2gsrw%3D (Pubitemid 32520881)
19. L Liu X Shao W Gao J Bai R Wang P Huang Y Yin P Liu Y Shu 2010 The role of human epidermal growth factor receptor 2 as a prognostic factor in lung cancer: a meta-analysis of published data J Thorac Oncol 5 1922 1932 21155183 10.1097/JTO.0b013e3181f26266
20. JR Molina P Yang SD Cassivi SE Schild AA Adjei 2008 Non-small cell lung cancer: epidemiology, risk factors, treatment and survivorship Mayo Clin Proc 83 584 594 18452692 10.4065/83.5.584 (Pubitemid 351720831)
21. H Nakamura N Kawahara M Taguchi K Kabasawa Association of HER-2 Overexpression with Prognosis in Nonsmall Cell Lung Carcinoma 2005 A metaanalysis Cancer 103 1865 1873 15770690 10.1002/cncr.20957 1:CAS:528:DC%2BD2MXktFGnsbc%3D (Pubitemid 40563259)
22. O Ogunwobi G Mutungi IL Beales 2006 Leptin stimulates proliferation and inhibits apoptosis in Barrett's esophageal adenocarcinoma cells by cyclooxygenase-2-dependent, prostaglandin-E2 mediated transactivation of the epidermal growth factor receptor and c-Jun NH2-terminal kinase activation Endocrinology 147 4505 4516 16740977 10.1210/en.2006-0224 1:CAS:528: DC%2BD28Xpt1Sisro%3D (Pubitemid 44268402)
23. P Pfeiffer PP Clausen K Andersen C Rose 1996 Lack of prognostic significance of epidermal growth factor receptor and the oncoprotein p185HER2 in patients with systemically untreated non-small-cell lung cancer: an immunohistochemical study on cryosections Br J Cancer 74 86 91 8679464 10.1038/bjc.1996.320 1:STN:280:DyaK283ns1egtw%3D%3D (Pubitemid 26231983)
24. RS Saad Y Liu H Han RJ Landreneau JF Silverman 2004 Prognostic significance of HER2/neu, p53 and vascular endothelial growth factor expression in early stage conventional and bronchioalveolar carcinoma of the lung Mod Pathol 17 1235 1242 15167937 10.1038/modpathol.3800171 1:CAS:528: DC%2BD2cXovFOqtrg%3D (Pubitemid 39328130)
25. S Scholl P Beuzeboc P Pouillart 2001 Targeting HER-2 in other tumor types Ann Oncol 12 S81 87 11521727 10.1023/A:1011192622688
26. A Serrano-Olvera A Dueñas-González D Gallardo-Rincón M Candelaria J De la Garza-Salazar 2006 Prognostic, predictive and therapeutic implications of HER-2 in invasive epithelial ovarian cancer Cancer Treat Rev 32 180 190 16483720 10.1016/j.ctrv.2006.01.001 1:CAS:528:DC%2BD28XjvFSgtro%3D
27. D Soma J Kitayama H Yamashita H Miyato M Ishikawa H Nagawa 2007 Leptin augments proliferation of breast cancer cells via transactivation of HER2 J Surg Res 149 9 14 18262553 10.1016/j.jss.2007.10.012
28. E Surmacz 2007 Obesity hormone leptin: a new target in breast cancer? Breast Cancer Res 9 301 17274833
29. A Terzidis TN Sergentanis G Antonopoulos C Syrigos A Efremidis A Polyzos N Dessypris ET Petridou 2009 Elevated serum leptin levels: a risk factor for non-small-cell lung cancer? Oncol 76 19 25 10.1159/000177952 1:CAS:528:DC%2BD1cXhsFarsbnE
30. L Zhao ZX Shen HS Luo L Shen 2005 Possible involvement of leptin and leptin receptor in developing gastric adenocarcinoma World J Gastroenterol 11 7666 7670 16437696 1:CAS:528:DC%2BD28Xhs1KlsLc%3D (Pubitemid 43168434)